FTSE All-Share
|
4 995,35
|
12,33
|
0,25 %
|
Analysen zu FTSE All-Share-Werten
| 29.04.24 | Diageo Sell | UBS AG | |
| 29.04.24 | GSK Buy | UBS AG | |
| 29.04.24 | Unilever Overweight | Barclays Capital | |
| 26.04.24 | AstraZeneca Halten | DZ BANK | |
| 26.04.24 | AstraZeneca Sell | UBS AG | |
| 26.04.24 | Unilever Sell | UBS AG | |
| 26.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 25.04.24 | Unilever Sector Perform | RBC Capital Markets | |
| 25.04.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 25.04.24 | AstraZeneca Sell | UBS AG | |
| 25.04.24 | Unilever Buy | Deutsche Bank AG | |
| 25.04.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 25.04.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 25.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 25.04.24 | Barclays Buy | UBS AG | |
| 25.04.24 | Barclays Outperform | RBC Capital Markets | |
| 25.04.24 | Unilever Sector Perform | RBC Capital Markets | |
| 24.04.24 | Unilever Sell | UBS AG | |
| 24.04.24 | Unilever Overweight | Barclays Capital | |
| 24.04.24 | BAT Neutral | UBS AG | |
| 24.04.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | AstraZeneca Outperform | Bernstein Research | |
| 24.04.24 | GSK Outperform | Bernstein Research | |
| 23.04.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | National Grid Buy | UBS AG | |
| 23.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.04.24 | BAT Buy | Jefferies & Company Inc. | |
| 22.04.24 | BAT Neutral | UBS AG | |
| 22.04.24 | Diageo Sell | Deutsche Bank AG | |
| 22.04.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 19.04.24 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 18.04.24 | Rio Tinto Overweight | Barclays Capital | |
| 18.04.24 | Diageo Outperform | Bernstein Research | |
| 18.04.24 | BP Outperform | RBC Capital Markets | |
| 18.04.24 | BP Buy | Jefferies & Company Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 4 |
| Diageo | 2 |
| GSK | 2 |
| BAT | 1 |
| Unilever | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.